Literature DB >> 8377697

Norfloxacin-induced hepatitis.

P Davoren, K Mainstone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8377697     DOI： 10.5694/j.1326-5377.1993.tb137931.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN： 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  4 in total

1.  Clinical and histopathologic features of fluoroquinolone-induced liver injury.

Authors:  Eric S Orman; Hari S Conjeevaram; Raj Vuppalanchi; James W Freston; James Rochon; David E Kleiner; Paul H Hayashi
Journal:  Clin Gastroenterol Hepatol       Date:  2011-02-26       Impact factor: 11.382

2.  Profiles of hepatic and dysrhythmic cardiovascular events following use of fluoroquinolone antibacterials: experience from large cohorts from the Drug Safety Research Unit Prescription-Event Monitoring database.

Authors:  D W Clark; D Layton; L V Wilton; G L Pearce; S A Shakir
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

3.  Resolution of norfloxacin-induced acute liver failure after N-acetylcysteine therapy: further support for the use of NAC in drug-induced ALF?

Authors:  Timothy Ross Elliott; Tiffany Symes; George Kannourakis; Peter Angus
Journal:  BMJ Case Rep       Date:  2016-01-06

Review 4.  Fluoroquinolone-induced liver injury: three new cases and a review of the literature.

Authors:  Anna Licata; Claudia Randazzo; Ilaria Morreale; Giuseppe Butera; Natale D'Alessandro; Antonio Craxì
Journal:  Eur J Clin Pharmacol       Date:  2012-01-14       Impact factor: 3.064
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.